HCA
stockKey statsas of May 22
- Open
- $394.00
- +0.37%
- Close
- $394.07
- +0.38%
- Current
- $394.07
- Prev close
- $392.56
- Today
- 1.11M
- 3-mo avg
- 1.20M
Stock health
A read across the data this app already carries: fundamentals, recent price and growth trajectory, and leadership stability. Industry context is not yet folded in.
For fun and reading at a glance. Not investment advice and not a buy or sell signal.
Overall, HCA reads as healthy.
- Fundamentals Strong across the nine graded ratios
- Trajectory Climbing trailing-year price trend + revenue / earnings growth
- Leadership — leadership sync has not reached this stock yet
Fundamentalssynced from SEC 1h ago
Across the nine graded ratios (FY2025 figures against the latest price), HCA’s fundamentals read as strong overall.
At 14x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 0.7% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 9.0% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
Shareholder equity is negative, so return on equity is not meaningful.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 11.2% return on assets is strong; the company squeezes good profit from its assets.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
Not enough data to compute debt-to-equity.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 0.97, short-term assets fall short of short-term bills; liquidity is tight.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 7.1% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 17.8% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 1h ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $58.8B | $60.2B | $65.0B | $70.6B | $75.6B |
| Net income | $7.0B | $5.6B | $5.2B | $5.8B | $6.8B |
| Diluted EPS | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 |
| Dividend / share | $1.92 | $2.24 | $2.40 | $2.64 | $2.88 |
| Total assets | $50.7B | $52.4B | $56.2B | $59.5B | $60.7B |
| Total liabilities | — | — | — | — | — |
| Shareholder equity | $1.5B | -$73.0M | $1.1B | -$2.5B | -$6.0B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.5B | $17.5B | $18.3B | $18.3B | $18.6B | $19.2B | $19.5B | $19.1B |
| Net income | $1.5B | $1.3B | $1.4B | $1.6B | $1.7B | $1.6B | $1.9B | $1.6B |
| Diluted EPS | $5.53 | $4.88 | $5.66 | $6.45 | $6.83 | $6.96 | $8.09 | $7.15 |
| Dividend / share | $0.66 | $0.66 | $0.66 | $0.72 | $0.72 | $0.72 | $0.72 | $0.78 |
Leadership
Notable recent eventspast year
- Apr 24 New 6-month low (-21% off peak)
- Apr 24 −8.8% one-day move
- Feb 25 Officer or director change reported in an 8-K
- Feb 11 +5.9% one-day move
- Jan 27 +7.1% one-day move
- Jul 11, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 2h ago
- 2025 total
- $2.88
- 2026 so far
- $0.781 payment
- 2026 projected
- $3.12+8.3% vs 2025
Projection scales HCA’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Mar 17 $0.78
- Dec 15, 2025 $0.72
- Sep 16, 2025 $0.72
- Jun 16, 2025 $0.72
- Mar 17, 2025 $0.72
- Dec 13, 2024 $0.66
- Sep 16, 2024 $0.66
- Jun 14, 2024 $0.66
- Mar 14, 2024 $0.66
- Dec 13, 2023 $0.60
- Sep 14, 2023 $0.60
- Jun 15, 2023 $0.60
- Mar 16, 2023 $0.60
- Dec 13, 2022 $0.56
- Sep 15, 2022 $0.56
- Jun 15, 2022 $0.56
- Mar 16, 2022 $0.56
- Dec 13, 2021 $0.48
- Sep 15, 2021 $0.48
- Jun 15, 2021 $0.48
Recent SEC filingssynced from SEC 1h ago
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report